GENESIS Biomed Revenue and Competitors

Barcelona, Spain

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GENESIS Biomed's estimated annual revenue is currently $3.4M per year.(i)
  • GENESIS Biomed's estimated revenue per employee is $155,000

Employee Data

  • GENESIS Biomed has 22 Employees.(i)
  • GENESIS Biomed grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.4M41N/AN/AN/A
#2
$0.9M6N/AN/AN/A
#3
$5.9M38N/AN/AN/A
#4
$47M30318%N/AN/A
#5
$9.5M6111%N/AN/A
#6
$46.7M30125%N/AN/A
#7
$1.7M11-8%N/AN/A
#8
$3.7M24-11%N/AN/A
#9
$4.2M2713%N/AN/A
#10
$5.3M346%N/AN/A
Add Company

What Is GENESIS Biomed?

GENESIS Biomed is a consulting company formed by entrepreneurs and with vocation of service to entrepreneurs and research centers. In GENESIS Biomed we offer consulting services, we invest in projects in seed stage and we develop our own R+D projects. Our sectors are biopharmaceutical, biotechnological, medical devices, in vitro diagnostic, foodtech, nutraceutical and cosmetic. We are born in May 2017 and we are located in the Barcelona Science Park.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GENESIS Biomed News

2022-04-20 - Secondary medication adherence patterns among tafamidis ...

Darrin Benjumea is an employee of Genesis Research who has been contracted by ... Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047.

2022-04-19 - Genesis Biomed y FI Group crean un vehículo de inversión ...

Las consultoras Genesis Biomed y FI Group, consultoras estratégicas y biomédicas han creado Genesis Tech Transfer Boost, han creado un...

2022-04-17 - Demand in the U.S. Animal Model Market is set to Increase at ...

... Harbour Biomed, Sinclair Bio Resources, Alpha Genesis Inc., Creative Animodel, DaVinci Biomedical Research Products, Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M22-4%N/A
#2
$2.2M22-15%N/A
#3
N/A225%N/A
#4
N/A22-21%N/A
#5
$2.3M23-28%N/A